Drug: humalog Quarter: 2016Q3
Total Records: 925 Number of Pages: 47
DRUGNAME | PT | EventCount |
---|---|---|
HUMALOG | Initial insomnia | 2 |
HUMALOG | Injection site atrophy | 2 |
HUMALOG | Injection site haematoma | 2 |
HUMALOG | Injection site induration | 2 |
HUMALOG | Injection site swelling | 2 |
HUMALOG | Injection site vesicles | 2 |
HUMALOG | Insulin C-peptide decreased | 2 |
HUMALOG | Intentional overdose | 2 |
HUMALOG | Irritability | 2 |
HUMALOG | Jaundice neonatal | 2 |
HUMALOG | Lethargy | 2 |
HUMALOG | Liver disorder | 2 |
HUMALOG | Lymphoma | 2 |
HUMALOG | Maternal exposure before pregnancy | 2 |
HUMALOG | Mesothelioma | 2 |
HUMALOG | Movement disorder | 2 |
HUMALOG | Multiple organ dysfunction syndrome | 2 |
HUMALOG | Multiple sclerosis | 2 |
HUMALOG | Muscle strain | 2 |
HUMALOG | Musculoskeletal stiffness | 2 |
Total Records: 925 Number of Pages: 47